Panacea Acquisition Corp. II

Panacea Acquisition Corp. II (Nasdaq: PANA) is a blank-check company focused on the healthcare and life sciences sector, sponsored by Panacea Acquisition Holdings II LLC. The vehicle completed its initial public offering in 2021 and was in its search phase for a business combination target at the time of its Form 10-Q filing with the SEC on August 13, 2021, accession number 0001213900-21-042562. Panacea II represented the second SPAC vehicle under the Panacea sponsor platform, which concentrated on identifying acquisition targets across biopharmaceuticals, medical technology, and adjacent healthcare verticals. Sign up for SpacDesk to access the full filing history, deal timeline, and real-time data on Panacea Acquisition Corp. II and hundreds of other SPACs.